1. Home
  2. NEUP vs WATT Comparison

NEUP vs WATT Comparison

Compare NEUP & WATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUP
  • WATT
  • Stock Information
  • Founded
  • NEUP 1996
  • WATT 2012
  • Country
  • NEUP United States
  • WATT United States
  • Employees
  • NEUP N/A
  • WATT N/A
  • Industry
  • NEUP
  • WATT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • NEUP
  • WATT Technology
  • Exchange
  • NEUP Nasdaq
  • WATT Nasdaq
  • Market Cap
  • NEUP 12.7M
  • WATT 10.6M
  • IPO Year
  • NEUP N/A
  • WATT 2014
  • Fundamental
  • Price
  • NEUP $11.89
  • WATT $6.70
  • Analyst Decision
  • NEUP Strong Buy
  • WATT
  • Analyst Count
  • NEUP 1
  • WATT 0
  • Target Price
  • NEUP $21.00
  • WATT N/A
  • AVG Volume (30 Days)
  • NEUP 67.0K
  • WATT 46.9K
  • Earning Date
  • NEUP 08-28-2025
  • WATT 07-29-2025
  • Dividend Yield
  • NEUP N/A
  • WATT N/A
  • EPS Growth
  • NEUP N/A
  • WATT N/A
  • EPS
  • NEUP 0.00
  • WATT N/A
  • Revenue
  • NEUP $15,662,715.00
  • WATT $1,976,000.00
  • Revenue This Year
  • NEUP N/A
  • WATT $1,028.91
  • Revenue Next Year
  • NEUP N/A
  • WATT $117.65
  • P/E Ratio
  • NEUP $3.84
  • WATT N/A
  • Revenue Growth
  • NEUP N/A
  • WATT 434.05
  • 52 Week Low
  • NEUP $2.90
  • WATT $3.67
  • 52 Week High
  • NEUP $126.00
  • WATT $81.00
  • Technical
  • Relative Strength Index (RSI)
  • NEUP 67.40
  • WATT 32.47
  • Support Level
  • NEUP $6.82
  • WATT $7.04
  • Resistance Level
  • NEUP $13.25
  • WATT $7.82
  • Average True Range (ATR)
  • NEUP 1.32
  • WATT 0.60
  • MACD
  • NEUP 0.44
  • WATT -0.02
  • Stochastic Oscillator
  • NEUP 77.78
  • WATT 5.10

About NEUP Neuphoria Therapeutics Inc. Common Stock

Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.

About WATT Energous Corporation

Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs, and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. The WPN technology provides a comprehensive suite of capabilities designed to power the next generation of wireless energy networks, seamlessly delivering power and data across diverse, battery-free device ecosystems. It enhances operational visibility, control, and intelligent business automation. Its products include Transmitter IC & Module, Receivers IC, Transmitter System, and Evaluation Kits.

Share on Social Networks: